Rosenblatt Securities Reaffirms Buy Rating for Synopsys (NASDAQ:SNPS)

Synopsys (NASDAQ:SNPS)‘s stock had its “buy” rating reissued by equities researchers at Rosenblatt Securities in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $575.00 price objective on the semiconductor company’s stock. Rosenblatt Securities’ price objective indicates a potential upside of 45.75% from the stock’s current price.

SNPS has been the subject of several other reports. Citigroup raised their target price on shares of Synopsys from $600.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research report on Thursday, May 28th. Benchmark reissued a “buy” rating on shares of Synopsys in a research note on Wednesday, August 19th. Bank of America lifted their price objective on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, KeyCorp reiterated an “overweight” rating on shares of Synopsys in a report on Wednesday, August 19th. Eleven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $563.59.

Synopsys Stock Performance

NASDAQ SNPS opened at $394.51 on Tuesday. The business has a 50 day moving average price of $418.53 and a 200 day moving average price of $439.92. The company has a market capitalization of $75.54 billion, a P/E ratio of 91.32, a PEG ratio of 2.34 and a beta of 1.23. Synopsys has a 1-year low of $366.00 and a 1-year high of $615.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the business earned $3.67 earnings per share. Synopsys’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts expect that Synopsys will post 10.64 EPS for the current fiscal year.

Insider Activity

In related news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by insiders.

Institutional Trading of Synopsys

A number of institutional investors have recently modified their holdings of SNPS. Sankala Group LLC acquired a new position in Synopsys during the fourth quarter valued at approximately $25,000. Elevation Wealth Partners LLC grew its stake in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares during the period. Osbon Capital Management LLC acquired a new stake in shares of Synopsys in the second quarter worth $25,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the 4th quarter valued at $28,000. Finally, IMG Wealth Management Inc. purchased a new position in shares of Synopsys in the 2nd quarter valued at $28,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.